These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 19963296

  • 1. A prospective observational trial on emesis in radiotherapy: analysis of 1020 patients recruited in 45 Italian radiation oncology centres.
    Maranzano E, De Angelis V, Pergolizzi S, Lupattelli M, Frata P, Spagnesi S, Frisio ML, Mandoliti G, Malinverni G, Trippa F, Fabbietti L, Parisi S, Di Palma A, De Vecchi P, De Renzis C, Giorgetti C, Bergami T, Orecchia R, Portaluri M, Signor M, Di Gennaro D, Italian Group for Antiemetic Research in Radiotherapy - IGARR.
    Radiother Oncol; 2010 Jan; 94(1):36-41. PubMed ID: 19963296
    [Abstract] [Full Text] [Related]

  • 2. Radiation-induced emesis: a prospective observational multicenter Italian trial. The Italian Group for Antiemetic Research in Radiotherapy.
    Int J Radiat Oncol Biol Phys; 1999 Jun 01; 44(3):619-25. PubMed ID: 10348292
    [Abstract] [Full Text] [Related]

  • 3. [Ondansetron in the prevention of radiation-induced nausea and emesis in patients treated with single-fraction irradiation].
    Jeremić B.
    Srp Arh Celok Lek; 1996 Jun 01; 124(5-6):131-4. PubMed ID: 9102832
    [Abstract] [Full Text] [Related]

  • 4. Radiation-induced emesis: effects of ondansetron.
    Scarantino CW, Ornitz RD, Hoffman LG, Anderson RF.
    Semin Oncol; 1992 Dec 01; 19(6 Suppl 15):38-43. PubMed ID: 1485181
    [Abstract] [Full Text] [Related]

  • 5. A comparative study of prophylactic antiemetic treatment in cancer patients receiving radiotherapy.
    Mystakidou K, Kouloulias V, Nikolaou V, Tsilika E, Lymperopoulou G, Balafouta M, Kouvaris I, Kelekis A, Gouliamos A.
    J BUON; 2010 Dec 01; 15(1):29-35. PubMed ID: 20414924
    [Abstract] [Full Text] [Related]

  • 6. Radiation-induced emesis: a problem with many open questions.
    Maranzano E.
    Tumori; 2001 Dec 01; 87(4):213-8. PubMed ID: 11693797
    [Abstract] [Full Text] [Related]

  • 7. Impact of chemotherapy-associated nausea and vomiting on patients' functional status and on costs: survey of five Canadian centres.
    O'Brien BJ, Rusthoven J, Rocchi A, Latreille J, Fine S, Vandenberg T, Laberge F.
    CMAJ; 1993 Aug 01; 149(3):296-302. PubMed ID: 8339175
    [Abstract] [Full Text] [Related]

  • 8. 5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19).
    National Cancer Institute of Canada Clinical Trials Group (SC19)National Cancer Institute of Canada Clinical Trials Group, Canada. Rebecca.wong@rmp.uhn.on.ca, Wong RK, Paul N, Ding K, Whitehead M, Brundage M, Fyles A, Wilke D, Nabid A, Fortin A, Wilson D, McKenzie M, Ackerman I, Souhami L, Chabot P, Pater J.
    J Clin Oncol; 2006 Jul 20; 24(21):3458-64. PubMed ID: 16849762
    [Abstract] [Full Text] [Related]

  • 9. International patterns of practice in the management of radiation therapy-induced nausea and vomiting.
    Dennis K, Zhang L, Lutz S, van Baardwijk A, van der Linden Y, Holt T, Arnalot PF, Lagrange JL, Maranzano E, Liu R, Wong KH, Wong LC, Vassiliou V, Corn BW, De Angelis C, Holden L, Wong CS, Chow E.
    Int J Radiat Oncol Biol Phys; 2012 Sep 01; 84(1):e49-60. PubMed ID: 22704982
    [Abstract] [Full Text] [Related]

  • 10. Radiotherapy-induced emesis. An overview.
    Feyer P, Zimmermann JS, Titlbach OJ, Buchali A, Hinkelbein M, Budach V.
    Strahlenther Onkol; 1998 Nov 01; 174 Suppl 3():56-61. PubMed ID: 9830459
    [Abstract] [Full Text] [Related]

  • 11. Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide.
    Shih V, Wan HS, Chan A.
    Ann Pharmacother; 2009 Mar 01; 43(3):444-52. PubMed ID: 19193584
    [Abstract] [Full Text] [Related]

  • 12. Incidence of chemotherapy-induced nausea and emesis after modern antiemetics.
    Grunberg SM, Deuson RR, Mavros P, Geling O, Hansen M, Cruciani G, Daniele B, De Pouvourville G, Rubenstein EB, Daugaard G.
    Cancer; 2004 May 15; 100(10):2261-8. PubMed ID: 15139073
    [Abstract] [Full Text] [Related]

  • 13. Optimising antiemetic therapy: what are the problems and how can they be overcome?
    Aapro M.
    Curr Med Res Opin; 2005 Jun 15; 21(6):885-97. PubMed ID: 15969889
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of the efficacy and safety of tropisetron, metoclopramide, and chlorpromazine in the treatment of emesis associated with far advanced cancer.
    Mystakidou K, Befon S, Liossi C, Vlachos L.
    Cancer; 1998 Sep 15; 83(6):1214-23. PubMed ID: 9740088
    [Abstract] [Full Text] [Related]

  • 18. Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational study.
    Booth CM, Clemons M, Dranitsaris G, Joy A, Young S, Callaghan W, Trudeau M, Petrella T.
    J Support Oncol; 2007 Sep 15; 5(8):374-80. PubMed ID: 17944146
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.